A multi-site observational study to assess safety and effectiveness of prenatal exposure to Dolutegravir in pregnant individuals living with HIV (212976)

First published 13/11/2019

Last updated 25/04/2024

EU PAS number:

EUPAS32268

Study

Finalised

Documents

Study protocol

Initial protocol

viiv-212976-protocol-redact

English (856.13 KB - PDF) View document

Study results

Study report

Clinical Study Report Anonymised 05 Apr 2024.pdf

English (1.89 MB - PDF) View document

Other information

Secondary tabs